Company Highlights Second Positive DSMB Review of Interim Data from Ovaprene® Phase 3 Clinical Trial, DARE to PLAY™ ...
Weekly ThreatsDay Bulletin: supply chain attacks, fake support lures, AI tampering, data leaks, ransomware, and exploited flaws.
Odysight.ai Inc. (NASDAQ/TASE: ODYS), a leader in AI-powered visual sensing and predictive maintenance (PdM) solutions for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results